logo

For the Inventor, By the Inventor

Combs la Ville, France

Frédéric Le Strat

This inventor holds 13 USPTO granted patents and 2 published patent applications and 11 EPO patents. Top assignees: Mutabilis, Laboratoire Biodim, Hivih. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frédéric Le Strat. Retrieved from https://idiyas.com/inventor/frédéric-le-strat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 53.8

 

Average Co-Inventor Count = 7.0

ph-index = 1


Location History:

  • Gagny, FR (2016 - 2018)
  • Paris, FR (2020)
  • Combs-la-Ville, FR (2016 - 2024)

Company Filing History:

goldMedal7 out of 10 
 
Mutabilis
 patents
silverMedal5 out of 7 
 
Laboratoire Biodim
 patents
bronzeMedal1 out of 1 
 
Hivih
 patent

Years Active: 2016-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11865118 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2024-01-09),
2. 11530227 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2022-12-20),
3. 10842779 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2020-11-24),
4. 10570131 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2020-02-25),
5. 10501481 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2019-12-10),
6. 10183943 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2019-01-22),
7. 10072006 - Heterocyclic compounds and their use in preventing or treating bacterial infections (2018-09-11),
8. 9994509 - Inhibitors of viral replication, their process of preparation and their therapeutical uses (2018-06-12),
9. 9604900 - Inhibitors of viral replication, their process of preparation and their therapeutical uses (2017-03-28),
10. 9562033 - Inhibitors of viral replication, their process of preparation and their therapeutical uses (2017-02-07),
11. 9475802 - Inhibitors of viral replication, their process of preparation and their therapeutical uses (2016-10-25),
12. 9260395 - Inhibitors of viral replication, their process of preparation and their therapeutical uses (2016-02-16),
13. 9238026 - Inhibitors of viral replication, their process of preparation and their therapeutical uses (2016-01-19),

Title: The Innovative Contributions of Frédéric Le Strat

Introduction: Frédéric Le Strat, an esteemed inventor based in Combs la Ville, France, has made significant contributions to the field of chemistry with 13 patents to his name. His work focuses primarily on the development of novel heterocyclic compounds aimed at combating bacterial infections, showcasing his commitment to advancing medical science.

Latest Patents: Among his most recent inventions are two notable patents concerning heterocyclic compounds. These compounds, as outlined in the patents, are designed for preventing or treating bacterial infections. They serve as antibacterial agents and β-lactamase inhibitors, demonstrating potential in improving the efficacy of treatments against resistant bacteria.

Career Highlights: Frédéric has had an impactful career, working with innovative companies such as Mutabilis and Laboratoire Biodim. His tenure in these organizations has allowed him to push the boundaries of pharmaceutical research and development.

Collaborations: Throughout his career, Frédéric has collaborated with talented individuals, including his coworkers Sophie Chasset and Francis Chevreuil. These partnerships have further enriched his work and contributed to the successful development of his inventions.

Conclusion: Frédéric Le Strat's contributions to the field of antibacterial research through his inventions and patents highlight the importance of innovation in medicine. His continued work promises to play a vital role in the ongoing fight against bacterial infections, benefitting society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…